Emerging and Re-emerging Coronaviruses

Section Editor(s): Dr. Susan R Weiss (Perelman School of Medicine, University of Pennsylvania, USA)

Emerging and re-emerging coronaviruses, including Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the latest COVID-19 (SARS-CoV-2) may cause epidemics or pandemics of highly pathogenic human infectious diseases, posing great threats to the global health. EMI's Special Issue on Emerging and Re-emerging Coronaviruses covers research and review articles on the basic, translational and clinical studies related to these coronaviruses.

Back to Sections

Modify your search

Advanced

Emerging Microbes & Infections sections

  • Showing 1-10 of 283 results for search:

Filters
Modify your search
Download citations Download PDFs
  2. Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control studyOpen Access
    Siyue Jia, Zundong Yin, Hongxing Pan, Fuzhen Wang, Xiaoqiang Liu, Qing Wang, Li Zhang, Jihai Tang, Hao Yang, Jiangbo Du, Zhiguo Wang, Pengfei Jin, Zhihang Peng, Rong Tang, Guodong Kang, Xuewen Wang, Simin Li, Weixiao Wang, Jingxin Li, Hongbing Shen & Fengcai Zhu
    Emerging Microbes & Infections, Volume 13, 2024 - Issue 1
    Article | Published online: 28 Apr 2024 | Views: 362
    Full Text
  4. Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in ChinaOpen Access
    Ying Liu, Jiayou Zhang, Wen Liu, Yongbing Pan, Shunan Ruan, Xuanxuan Nian, Wei Chen, Lina Sun, Qiangling Yin, Xin Yue, Qingliang Li, Fang Gui, Cong Wu, Shuzhen Wang, Yunkai Yang, Zhaofei Jing, Feiguang Long, Zejun Wang, Zeyu Zhang, Chaolin Huang, Kai Duan, Mifang Liang & Xiaoming Yang
    Emerging Microbes & Infections, Volume 13, 2024 - Issue 1
    Article | Published online: 26 Mar 2024 | Views: 1510
    Full Text
  7. The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trialOpen Access
    Chunhua Zhou, Yuanzheng Qiu, Jianxin Wang, Xiang Zhong, Xiufang Zhu, Xiaojing Huang, Lan Yang, Qiaolei Ji, Feifei Zhou, Shunquan Wu, Mengjie Yang, Jing Zhang, Kaili Liu, Li Ji, Hanyu Yang, Chunlei Li & Yuanyuan Zhao
    Emerging Microbes & Infections, Volume 13, 2024 - Issue 1
    Article | Published online: 29 Feb 2024 | Views: 588
    Full Text
  9. Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trialOpen Access
    Jia-Wei Xu, Bu-Sen Wang, Ping Gao, Hai-Tao Huang, Fei-Yu Wang, Wei Qiu, Yuan-Yuan Zhang, Yu Xu, Jin-Bo Gou, Lin-Ling Yu, Xuan Liu, Rui-Jie Wang, Tao Zhu, Li-Hua Hou & Qing- Wang
    Emerging Microbes & Infections, Volume 13, 2024 - Issue 1
    Article | Published online: 30 Dec 2023 | Views: 2719 | Citations: 1
    Full Text
  10. An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoVOpen Access
    Hailong Guo, Bomsoo Cho, Paul R. Hinton, Sijia He, Yongjun Yu, Ashwin Kumar Ramesh, Jwala Priyadarsini Sivaccumar, Zhiqiang Ku, Kristen Campo, Sarah Holland, Sameer Sachdeva, Christopher Mensch, Mohamed Dawod, Annalis Whitaker, Philip Eisenhauer, Allison Falcone, Rebekah Honce, Jason W. Botten, Stephen F. Carroll, Bruce A. Keyt, Andrew W. Womack, William R. Strohl, Kai Xu, Ningyan Zhang, Zhiqiang An, Sha Ha, John W. Shiver & Tong-Ming Fu
    Emerging Microbes & Infections, Volume 12, 2023 - Issue 2
    Article | Published online: 11 Dec 2023 | Views: 1400 | Citations: 1
    Full Text